Study of the Fe 3 O 4 @ZIF-8@Sor Composite Modified by Tannic Acid for the Treatment of Sorafenib-Resistant Hepatocellular Carcinoma
ACS Omega · 24.10.2023 · 8 (42) · 39174-39185
DOI: 10.1021/acsomega.3c04215 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 12.09.2023. Verfasst von Jianqiao Kong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang City 441000, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative Research Program of Xiangyang No.1 People's Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of General Surgery, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang City 441000, China.
ORCID-Profile: Peng Zhang
Förderung
- Innovative Research Program of Xiangyang No.1 People's Hospital
Zitieren
APA
Kong, J., Xu, S., Dai, Y., Wang, Y., Zhao, Y., & Zhang, P. (2023). Study of the Fe 3 O 4 @ZIF-8@Sor Composite Modified by Tannic Acid for the Treatment of Sorafenib-Resistant Hepatocellular Carcinoma. ACS Omega, 8(42), 39174-39185. https://doi.org/10.1021/acsomega.3c04215
Vancouver
Kong J, Xu S, Dai Y, Wang Y, Zhao Y, Zhang P. Study of the Fe 3 O 4 @ZIF-8@Sor Composite Modified by Tannic Acid for the Treatment of Sorafenib-Resistant Hepatocellular Carcinoma. ACS Omega. 2023;8(42):39174-39185. doi:10.1021/acsomega.3c04215
BibTeX
@article{Kong2023,
author = {Kong, Jianqiao and Xu, Song and Dai, Yang and Wang, Yi and Zhao, Yun and Zhang, Peng},
title = {Study of the Fe 3 O 4 @ZIF-8@Sor Composite Modified by Tannic Acid for the Treatment of Sorafenib-Resistant Hepatocellular Carcinoma},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {42},
pages = {39174--39185},
doi = {10.1021/acsomega.3c04215}
}
EUVIMED